Annex 4 Application of the Australian Aid Policy tests to health – This means that DFAT Aid Policy Tests Health diplomacy and Considerations/criteria Findings for HSSP2 investments will…. Are public health issues, antimicrobial resistance in • prioritise low and except for Pursuing national Not significantly • • – the region and future epidemics a potential threat to interest and middle-income countries malaria where HSSP2 has supported Australia’s interests? extending in the Indo-Pacific efforts in malaria elimination. Australia’s Pacific region Can Australia be a significant and valuable health • YES. Australia is THE significant and • player in the region? influence reflect Australia’s valuable player and the SI SWAp is a • broader strategic and flagship program of support Does the investment benefit DFAT’s priority countries • political priorities and in the Indo-Pacific region? Does it benefit countries in YES. Specifically the Pacific • comparative advantage Southeast Asia and the Pacific in particular? (e.g. geographic YES Is health a priority sector in the relevant DFAT country • proximity and priority • relationships) and regional Aid Investment Plans? promote regional • NO. May reduces Solomon Islanders Does the investment prevent or mitigate a public • • security, stability and coming to Australia for treatment. health threat to Australia, to the region, and globally? prosperity through YES. HSSP2 has been a major • Does the investment prevent health-related instability • addressing health contributor to the RAMSI led in the region and thereby contribute to economic and related development stabilisation mission. human development? and economic risks NO • Does the investment promote a regional solution to • cross-border disease threats, such as antimicrobial resistance in the region? Impact on target health system Is poor health limiting partner countries’ progress with YES. See world Bank and IMF • • • constraints to address economic growth and poverty reduction? studies. promoting growth and reducing countries’ priority health Does the investment focus on benefitting the poor? - on poor. All population will YES • • challenges including poverty Who will benefit? What is the evidence for this? (e.g. benefit with focus on provincial level
Annex 4 – Application of the Australian Aid Policy tests to health Aid Policy Tests This means that DFAT Health diplomacy and investments will…. Considerations/criteria Findings for HSSP2 Pursuing national interest and extending Australia’s influence • prioritise low and middle-income countries in the Indo-Pacific Pacific region • reflect Australia’s broader strategic and political priorities and comparative advantage (e.g. geographic proximity and priority relationships) • promote regional security, stability and prosperity through addressing health related development and economic risks • Are public health issues, antimicrobial resistance in the region and future epidemics a potential threat to Australia’s interests? • Can Australia be a significant and valuable health player in the region? • Does the investment benefit DFAT’s priority countries in the Indo-Pacific region? Does it benefit countries in Southeast Asia and the Pacific in particular? • Is health a priority sector in the relevant DFAT country and regional Aid Investment Plans? • Does the investment prevent or mitigate a public health threat to Australia, to the region, and globally? • Does the investment prevent health-related instability in the region and thereby contribute to economic and human development? • Does the investment promote a regional solution to cross-border disease threats, such as antimicrobial resistance in the region? • Not significantly – except for malaria where HSSP2 has supported efforts in malaria elimination. • YES. Australia is THE significant and valuable player and the SI SWAp is a flagship program of support • YES. Specifically the Pacific • YES • NO. May reduces Solomon Islanders coming to Australia for treatment. • YES. HSSP2 has been a major contributor to the RAMSI led stabilisation mission. • NO Impact on promoting growth and reducing poverty • target health system constraints to address countries’ priority health challenges including • Is poor health limiting partner countries’ progress with economic growth and poverty reduction? • Does the investment focus on benefitting the poor? Who will benefit? What is the evidence for this? (e.g. • YES. See world Bank and IMF studies. • YES - on poor. All population will benefit with focus on provincial level
independent-completion-report-to-the-solomon-islands-health-sector-support-program.docx